Records containing: Influenza, Human
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-11Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
-
CLINICAL_TRIALS study record update · 2021-06-29Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects
-
CLINICAL_TRIALS study record update · 2021-05-07Reactogenicity, Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults
-
CLINICAL_TRIALS study record update · 2021-02-02Randomized Clinical Trial of Multi-respiratory Pathogen Testing Versus Usual Care in Emergency Department (ED) Patients With Upper Respiratory Symptoms
-
CLINICAL_TRIALS study record update · 2021-02-01Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-01-19Phase IV Study Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza: A Randomized, Double-Blind Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-11-03Duration of Prophylactic Treatment With Oseltamivir: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-10-22A Phase III/IV, Stratified, Randomized, Observer Blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Influenza Comparator Vaccine in Subjects ≥2 to <18 Years of Age
-
CLINICAL_TRIALS study record update · 2020-08-31A Multi-center, Randomized, Double-blind, and Placebo-controlled Phase II Clinical Study to Investigate the Safety and Efficacy of Two Doses of KT07 Compared to Placebo in Subjects With Acute Uncomplicated Influenza
-
CLINICAL_TRIALS study record update · 2020-07-22A Phase 3, Randomized, Double-Blind, Controlled, Multicenter, Clinical Study to Evaluate Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Influenza Vaccine in Comparison With an MF59-Adjuvanted Trivalent Subunit Influenza Vaccine and an MF59-Adjuvanted Trivalent Subunit Influenza Vaccine Containing the Alternate B Strain, in Adults Aged 65 Years and Above
-
CLINICAL_TRIALS study record update · 2020-06-16Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities
-
CLINICAL_TRIALS study record update · 2020-05-11Phase III Study to Evaluate Immunogenicity and Safety of 'Il-Yang Quadrivalent Seasonal Influenza Vaccine' in Healthy Korean Children and Adolescents
-
CLINICAL_TRIALS study record update · 2020-05-04An Open-Label, Ascending Dose Study to Determine the Safety and Attack Rate of a Wild Type, Seasonal H3N2 Influenza Challenge Agent in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-04-08Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccines
-
CLINICAL_TRIALS study record update · 2020-03-03Prevalence, Strain Circulation and Disease Burden of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015
-
CLINICAL_TRIALS study record update · 2020-01-28Burden of Influenza at Emergency Department (ED) Level in European Countries
-
CLINICAL_TRIALS study record update · 2020-01-13Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England 2017/18
-
CLINICAL_TRIALS study record update · 2019-11-13Evaluation of the Immunogenicity, Relative Efficacy, Safety and Reactogenicity of Flublok Quadrivalent® (Quadrivalent Recombinant Influenza Vaccine, Seasonal Formulation) Compared With a Marketed Quadrivalent Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years-old.
-
CLINICAL_TRIALS study record update · 2019-11-12Immunologic Response to Influenza Vaccination in Children and Adolescents: A RCT Trial of Influenza Vaccines
-
CLINICAL_TRIALS study record update · 2019-10-21A Randomized Controlled Trial on the Treatment of Severe Influenza A Infection
-
CLINICAL_TRIALS study record update · 2019-09-25Randomized, Double-Blinded, Phase 2 Study to Assess Safety and Immunogenicity of Panblok H7 Vaccine at Three Antigen Dose Levels Adjuvanted With AS03® or MF59®
-
CLINICAL_TRIALS study record update · 2019-09-06A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
-
CLINICAL_TRIALS study record update · 2019-08-29Can Uptake of Childhood Influenza Immunisation in GP Practices be Increased Through Behavioural-insight Informed Changes to the Invitation Process?
-
CLINICAL_TRIALS study record update · 2019-08-05Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-07-22A Phase 2/3 Double Blinded, Randomized, Placebo-Controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced by IVAC